Phibro Animal Health (PAHC) Total Debt (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Total Debt came in at $620.5 million in Q1 2026, down 2.34% year-on-year from $635.4 million in Q1 2025, and down 0.6% quarter-over-quarter from $624.2 million in Q4 2025.
Phibro Animal Health (PAHC) Total Debt (2013 - 2026) Analysis & Trends
Phibro Animal Health's Total Debt history runs 14 years deep, the most recent figure standing at $620.5 million for Q1 2026.
- On a quarterly basis, Total Debt fell 2.34% year-over-year to $620.5 million in Q1 2026; TTM through Mar 2026 was $620.5 million, a 2.34% decrease from a year earlier, with the FY2025 full-year figure at $103.2 million, down 49.83% from the prior year.
- Total Debt declined to $620.5 million in Q1 2026 per PAHC's latest filing, from $624.2 million in the prior quarter.
- Across five years, Total Debt topped out at $635.4 million in Q1 2025 and bottomed at $103.2 million in Q2 2025.
- The 5-year median for Total Debt is $205.8 million (2024), against an average of $298.5 million.
- Across the five-year window, Total Debt slumped 59.79% in 2024 and surged 379.26% in 2025, its largest moves.
- Year by year, Total Debt stood at $292.2 million in 2022, then grew by 10.84% to $323.9 million in 2023, then slumped by 59.79% to $130.2 million in 2024, then surged by 379.26% to $624.2 million in 2025, then decreased by 0.6% to $620.5 million in 2026.
- Per Business Quant, the three latest PAHC Total Debt figures stand at $620.5 million (Q1 2026), $624.2 million (Q4 2025), and $628.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 11.45 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 16.63 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 28.76 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 7.15 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.34 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.81 Bn |
| 10 | Phibro Animal Health | 1.38 Bn | 1.30 Bn | 125.68 Mn | 620.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 620.52 Mn |
| Dec 31, 2025 | 624.24 Mn |
| Sep 30, 2025 | 627.96 Mn |
| Jun 30, 2025 | 103.25 Mn |
| Mar 31, 2025 | 635.41 Mn |
| Dec 31, 2024 | 130.25 Mn |
| Sep 30, 2024 | 186.50 Mn |
| Jun 30, 2024 | 205.80 Mn |
| Mar 31, 2024 | 194.81 Mn |
| Dec 31, 2023 | 323.90 Mn |
| Sep 30, 2023 | 178.15 Mn |
| Jun 30, 2023 | 163.30 Mn |
| Mar 31, 2023 | 208.42 Mn |
| Dec 31, 2022 | 292.23 Mn |
| Sep 30, 2022 | 296.16 Mn |
| Jun 30, 2022 | 160.00 Mn |
| Mar 31, 2022 | 124.00 Mn |
| Dec 31, 2021 | 293.44 Mn |
| Sep 30, 2021 | 114.84 Mn |
| Jun 30, 2021 | 104.38 Mn |